April 24, 2020 / 4:56 PM / a month ago

BRIEF-Hoth Therapeutics, Voltron Therapeutics & Halovax Announce Selection Of First Of Two Sets Of Virus Targeting Peptides For Animal Testing In Development Of Covid-19 Vaccine

April 24 (Reuters) - Hoth Therapeutics Inc:

* HOTH THERAPEUTICS, INC., VOLTRON THERAPEUTICS, INC., & HALOVAX ANNOUNCE SELECTION OF THE FIRST OF TWO SETS OF VIRUS TARGETING PEPTIDES FOR ANIMAL TESTING IN THE DEVELOPMENT OF A COVID-19 VACCINE

* HOTH THERAPEUTICS - INITIATION OF 1ST ANIMAL STUDY FOR COVID-19 VACCINE CANDIDATES EXPECTED TO BEGIN DURING MAY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below